These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18281245)

  • 1. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer.
    Morikawa A; Ohara N; Xu Q; Nakabayashi K; DeManno DA; Chwalisz K; Yoshida S; Maruo T
    Hum Reprod; 2008 Apr; 23(4):944-51. PubMed ID: 18281245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
    Xu Q; Ohara N; Liu J; Amano M; Sitruk-Ware R; Yoshida S; Maruo T
    Mol Hum Reprod; 2008 Mar; 14(3):181-91. PubMed ID: 18216291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
    Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
    Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth.
    Yoshida S; Ohara N; Xu Q; Chen W; Wang J; Nakabayashi K; Sasaki H; Morikawa A; Maruo T
    Semin Reprod Med; 2010 May; 28(3):260-73. PubMed ID: 20414849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective progesterone receptor modulator asoprisnil induces endoplasmic reticulum stress in cultured human uterine leiomyoma cells.
    Xu Q; Ohara N; Liu J; Nakabayashi K; DeManno D; Chwalisz K; Yoshida S; Maruo T
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1002-11. PubMed ID: 17652152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
    Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
    Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
    Sasaki H; Ohara N; Xu Q; Wang J; DeManno DA; Chwalisz K; Yoshida S; Maruo T
    J Clin Endocrinol Metab; 2007 Feb; 92(2):616-23. PubMed ID: 17105846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells.
    Chen W; Ohara N; Wang J; Xu Q; Liu J; Morikawa A; Sasaki H; Yoshida S; Demanno DA; Chwalisz K; Maruo T
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1296-304. PubMed ID: 16464945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells.
    Xu Q; Ohara N; Chen W; Liu J; Sasaki H; Morikawa A; Sitruk-Ware R; Johansson ED; Maruo T
    Hum Reprod; 2006 Sep; 21(9):2408-16. PubMed ID: 16720624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system.
    Maruo T; Ohara N; Yoshida S; Nakabayashi K; Sasaki H; Xu Q; Chen W; Yamada H
    Contraception; 2010 Nov; 82(5):435-41. PubMed ID: 20933117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP
    Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
    Schmidt R; Bültmann A; Ungerer M; Joghetaei N; Bülbül O; Thieme S; Chavakis T; Toole BP; Gawaz M; Schömig A; May AE
    Circulation; 2006 Feb; 113(6):834-41. PubMed ID: 16461815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium.
    Bogusiewicz M; Stryjecka-Zimmer M; Postawski K; Jakimiuk AJ; Rechberger T
    Gynecol Endocrinol; 2007 Sep; 23(9):541-6. PubMed ID: 17943549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata.
    Williams AR; Critchley HO; Osei J; Ingamells S; Cameron IT; Han C; Chwalisz K
    Hum Reprod; 2007 Jun; 22(6):1696-704. PubMed ID: 17339234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
    Braundmeier AG; Nowak RA
    Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P regulates the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in cultured human gingival fibroblasts.
    Cury PR; Canavez F; de Araújo VC; Furuse C; de Araújo NS
    J Periodontal Res; 2008 Jun; 43(3):255-60. PubMed ID: 18179473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J; Windsor LJ
    J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
    Philips N; Conte J; Chen YJ; Natrajan P; Taw M; Keller T; Givant J; Tuason M; Dulaj L; Leonardi D; Gonzalez S
    Arch Dermatol Res; 2009 Aug; 301(7):487-95. PubMed ID: 19373483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
    Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
    Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.